A carregar...
miR-96 induces cisplatin chemoresistance in non-small cell lung cancer cells by downregulating SAMD9
Cisplatin is effective as a single agent or in combination with other drugs for the treatment of non-small cell lung cancer (NSCLC). A concerning clinical challenge with cisplatin-based NSCLC chemotherapy is the intrinsic and acquired chemoresistance to cisplatin. The sterile α motif domain-containi...
Na minha lista:
| Publicado no: | Oncol Lett |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4734049/ https://ncbi.nlm.nih.gov/pubmed/26893673 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.4000 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|